Becton Dickinson and Company Profile (NYSE:BDX)

About Becton Dickinson and

Becton Dickinson and logoBecton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company operates through two business segments: BD Medical, which consists of Diabetes Care, Medication and Procedural Solutions, Medication Management Solutions, Pharmaceutical Systems and Respiratory Solutions business units, and BD Life Sciences, which consists of Preanalytical Systems, Diagnostic Systems and Biosciences business units. The Company's products include hypodermic needles and syringes; insulin syringes and pen needles; BD Hypak brand prefillable syringe systems; infusion therapy products, including Alaris infusion pumps; BD Vacutainer brand blood collection products, and flow cytometry instruments and reagents.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: BDX
  • CUSIP: 07588710
Key Metrics:
  • Previous Close: $178.97
  • 50 Day Moving Average: $175.60
  • 200 Day Moving Average: $167.55
  • 52-Week Range: $129.50 - $181.76
  • Trailing P/E Ratio: 34.14
  • Foreward P/E Ratio: 18.94
  • P/E Growth: 1.54
  • Market Cap: $38.09B
  • Outstanding Shares: 212,925,000
  • Beta: 0.97
  • Net Margins: 9.24%
  • Return on Equity: 24.26%
  • Return on Assets: 6.94%
  • Debt-to-Equity Ratio: 1.31%
  • Current Ratio: 1.55%
  • Quick Ratio: 1.11%
Additional Links:
Companies Related to Becton Dickinson and:

Analyst Ratings

Consensus Ratings for Becton Dickinson and (NYSE:BDX) (?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings, 8 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $171.25 (4.42% downside)

Analysts' Ratings History for Becton Dickinson and (NYSE:BDX)
DateFirmActionRatingPrice TargetDetails
9/23/2016Citigroup Inc.DowngradeNeutral -> Sell$167.00 -> $165.00View Rating Details
8/16/2016Cowen and CompanyReiterated RatingOutperform$185.00View Rating Details
8/9/2016Leerink SwannReiterated RatingHoldView Rating Details
8/5/2016Jefferies GroupReiterated RatingBuyView Rating Details
7/12/2016Bank of America Corp.Reiterated RatingBuyView Rating Details
6/12/2016ArgusReiterated RatingBuyView Rating Details
6/1/2016Evercore ISIDowngradeBuy -> HoldView Rating Details
5/9/2016Royal Bank Of CanadaBoost Price TargetSector Perform$153.00 -> $169.00View Rating Details
5/8/2016Morgan StanleyReiterated RatingHoldView Rating Details
5/3/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details
4/8/2016Goldman Sachs Group Inc.Boost Price Target$156.00 -> $157.00View Rating Details
2/11/2016Deutsche Bank AGUpgradeHold -> Buy$155.00 -> $163.00View Rating Details
12/11/2015Raymond James Financial Inc.Boost Price TargetStrong-Buy$172.00 -> $176.00View Rating Details
11/22/2015Piper Jaffray Cos.Reiterated RatingOverweight$160.00 -> $171.00View Rating Details
11/19/2015William BlairReiterated RatingOutperformView Rating Details
7/2/2015Barclays PLCReiterated RatingEqual Weight$158.00 -> $158.00View Rating Details
5/7/2015Canaccord GenuitySet Price TargetHold$145.00View Rating Details
1/9/2015SunTrust Banks Inc.DowngradeBuy -> NeutralView Rating Details
10/7/2014Stifel NicolausUpgradeHold -> Buy$153.00View Rating Details
(Data available from 9/28/2014 forward)


Earnings History for Becton Dickinson and (NYSE:BDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q316$2.21$2.35$3.21 billion$3.20 billionViewListenView Earnings Details
5/5/2016Q216$2.02$2.18$3.07 billion$3.07 billionViewListenView Earnings Details
2/3/2016Q116$1.84$1.96$3.04 billion$2.99 billionViewListenView Earnings Details
11/4/2015Q415$1.90$1.94$3.04 billion$3.07 billionViewListenView Earnings Details
8/6/2015Q315$2.01$2.05$3.13 billion$3.12 billionViewListenView Earnings Details
5/7/2015Q2$1.53$1.61$2.05 billion$2.05 billionViewListenView Earnings Details
2/5/2015Q115$1.45$1.53$2.04 billion$2.05 billionViewListenView Earnings Details
11/4/2014Q414$1.66$1.68$2.16 billion$2.20 billionViewListenView Earnings Details
7/31/2014Q314$1.67$1.65$2.14 billion$2.16 billionViewListenView Earnings Details
5/1/2014Q2$1.50$1.45$2.09 billion$2.07 billionViewListenView Earnings Details
2/4/2014Q114$1.30$1.42$1.98 billion$2.00 billionViewListenView Earnings Details
11/5/2013Q413$1.46$1.52$2.05 billion$2.10 billionViewListenView Earnings Details
8/1/2013Q3 2013$1.48$1.58$2.05 million$2.05 billionViewListenView Earnings Details
5/2/2013Q2 2013$1.35$1.44$1.99 billion$2.00 billionViewListenView Earnings Details
2/5/2013Q1 2013$1.24$1.35$1.86 billion$1.90 billionViewListenView Earnings Details
11/7/2012Q412$1.40$1.42$1.96 billion$1.97 billionViewN/AView Earnings Details
8/2/2012$1.53$1.52ViewN/AView Earnings Details
5/1/2012$1.38$1.38ViewN/AView Earnings Details
2/7/2012$1.17$1.21ViewN/AView Earnings Details
11/2/2011$1.41$1.39ViewN/AView Earnings Details
8/2/2011$1.43$1.53ViewN/AView Earnings Details
4/26/2011$1.30$1.38ViewN/AView Earnings Details
2/7/2011$1.29$1.35ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Becton Dickinson and (NYSE:BDX)
Current Year EPS Consensus Estimate: $8.57 EPS
Next Year EPS Consensus Estimate: $9.46 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$1.87$1.94$1.91
Q2 20164$2.26$2.39$2.33
Q3 20163$2.28$2.31$2.29
Q4 20161$2.15$2.15$2.15
Q1 20171$2.35$2.35$2.35
Q2 20171$2.31$2.31$2.31
Q3 20171$2.33$2.33$2.33
Q4 20171$2.42$2.42$2.42
(Data provided by Zacks Investment Research)


Current Dividend Information for Becton Dickinson and (NYSE:BDX)
Annual Dividend:$2.64
Dividend Yield:1.47%
Dividend Growth:10.10% (3 Year Average)
Payout Ratio:50.19% (Based on Trailing 12 Months of Earnings)
30.81% (Based on Current Year Consensus EPS Estimate)
27.91% (Based on Next Year Consensus EPS Estimate)
Track Record:44 Years of Consecutive Dividend Growth

Dividend History for Becton Dickinson and (NYSE:BDX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Becton Dickinson and (NYSE:BDX)
Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 81.96%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2016Linda M TharbyInsiderSell11,704$177.27$2,074,768.08View SEC Filing  
8/11/2016Gary M CohenInsiderSell29,367$176.81$5,192,379.27View SEC Filing  
6/13/2016John E GallagherVPSell1,931$169.87$328,018.97View SEC Filing  
6/7/2016Nabil ShabshabEVPSell5,080$168.75$857,250.00View SEC Filing  
5/17/2016Jeffrey S ShermanVPSell34,373$166.27$5,715,198.71View SEC Filing  
5/13/2016Stephen SichakEVPSell12,995$166.48$2,163,407.60View SEC Filing  
5/13/2016Vincent A ForlenzaCEOSell37,933$166.17$6,303,326.61View SEC Filing  
5/10/2016James F OrrDirectorSell1,368$167.66$229,358.88View SEC Filing  
5/9/2016James C LimEVPSell5,257$165.60$870,559.20View SEC Filing  
5/6/2016Ellen R StrahlmanSVPSell3,019$163.52$493,666.88View SEC Filing  
5/6/2016Jerome V HurwitzEVPSell3,878$163.58$634,363.24View SEC Filing  
5/6/2016Rebecca W RimelDirectorSell684$163.69$111,963.96View SEC Filing  
12/14/2015Stephen SichakEVPSell8,670$152.21$1,319,660.70View SEC Filing  
12/9/2015William A KozyEVPSell15,495$154.43$2,392,892.85View SEC Filing  
12/8/2015Vincent A. ForlenzaCEOSell17,762$153.10$2,719,362.20View SEC Filing  
12/7/2015Jeffrey S ShermanVPSell7,586$153.76$1,166,423.36View SEC Filing  
12/1/2015Thomas E Polen JrEVPSell2,683$152.21$408,379.43View SEC Filing  
11/30/2015John E GallagherVPSell1,600$150.70$241,120.00View SEC Filing  
11/18/2015Jerome V. HurwitzEVPSell2,347$151.02$354,443.94View SEC Filing  
6/1/2015Stephen SichakEVPSell12,188$140.94$1,717,776.72View SEC Filing  
5/22/2015Thomas E Polen JrEVPSell3,882$142.56$553,417.92View SEC Filing  
5/21/2015Linda M TharbyEVPSell6,069$142.02$861,919.38View SEC Filing  
5/20/2015William A KozyEVPSell10,326$142.00$1,466,292.00View SEC Filing  
5/19/2015William A KozyEVPSell10,435$142.01$1,481,874.35View SEC Filing  
5/18/2015Bertram L ScottDirectorSell2,160$141.74$306,158.40View SEC Filing  
5/18/2015James C LimEVPSell3,604$141.80$511,047.20View SEC Filing  
5/15/2015Alexandre ConroyEVPSell1,291$141.37$182,508.67View SEC Filing  
5/13/2015Jeffrey S ShermanVPSell10,983$138.40$1,520,047.20View SEC Filing  
5/11/2015Jerome V HurwitzEVPSell1,197$141.43$169,291.71View SEC Filing  
5/8/2015Gary M CohenEVPSell13,490$142.90$1,927,721.00View SEC Filing  
6/12/2014Stephen SichakSVPSell1,456$118.25$172,172.00View SEC Filing  
6/10/2014Gary M CohenEVPSell12,476$119.24$1,487,638.24View SEC Filing  
6/9/2014Jeffrey S ShermanVPSell7,877$120.24$947,130.48View SEC Filing  
3/6/2014Jeffrey ShermanVPSell1,303$115.16$150,053.48View SEC Filing  
11/12/2013William KozyEVPSell9,597$108.30$1,039,355.10View SEC Filing  
11/11/2013Jeffrey ShermanVPSell4,272$107.78$460,436.16View SEC Filing  
11/11/2013Jerome HurwitzSVPSell1,151$107.78$124,054.78View SEC Filing  
11/8/2013Vincent ForlenzaCEOSell32,411$107.39$3,480,617.29View SEC Filing  
11/6/2013Henry Becton, Jr.DirectorSell2,276$106.77$243,008.52View SEC Filing  
8/23/2013Bertram ScottDirectorSell4,047$98.61$399,074.67View SEC Filing  
8/8/2013Edward DegraanDirectorSell4,436$100.03$443,733.08View SEC Filing  
8/8/2013Stephen SichakSVPSell3,431$100.13$343,546.03View SEC Filing  
8/7/2013Basil AndersonDirectorSell2,160$99.79$215,546.40View SEC Filing  
5/22/2013Henry P Becton JrDirectorSell3,117$101.86$317,497.62View SEC Filing  
5/17/2013Donna M BolesVPSell2,415$101.38$244,832.70View SEC Filing  
5/13/2013Gary M CohenEVPSell8,753$100.22$877,225.66View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Becton Dickinson and (NYSE:BDX)
News IconTop Gainers of the Day: Becton, Dickinson and Company (NYSE:BDX) from Medical Instruments & Supplies (NYSE:BDX) - September 27 at 3:45 PM logoETF’s with exposure to Becton, Dickinson & Co. : September 27, 2016 (NYSE:BDX) - September 27 at 3:45 PM
News IconAnalyst's Reviews on Rating under Consideration: Becton Dickinson and Co (NYSE:BDX) - Post Registrar (NYSE:BDX) - September 26 at 3:57 PM
News IconPay Close Attention To These Analyst Ratings Becton Dickinson and Co (NYSE:BDX), 3M Co (NYSE:MMM) - The Voice Registrar (NYSE:BDX) - September 26 at 8:33 AM logoThese 5 Rocket Stocks Are Ready for Blastoff (NYSE:BDX) - September 26 at 8:33 AM
News IconMedical Instruments & Supplies: Becton, Dickinson and Company (NYSE:BDX) Position of the day (NYSE:BDX) - September 24 at 9:05 AM logoBecton Dickinson and : , Dickinson (BDX) Launch Wireless Diagnostic Device (NYSE:BDX) - September 24 at 9:05 AM logoBecton, Dickinson and Company (NYSE:BDX) Mean Price Target Is $185 (NYSE:BDX) - September 23 at 4:11 PM logoBecton Dickinson (BDX) Plans $100M Expansion of Holdrege, Nebraska, Plant - (NYSE:BDX) - September 22 at 3:55 PM logoBD Unveils Next Generation Wireless Point-of-Care Diagnostic Device - PR Newswire (press release) (NYSE:BDX) - September 22 at 9:39 AM logoBecton, Dickinson and Company (NYSE:BDX): Analyst Rating ... - Investor Newswire (NYSE:BDX) - September 21 at 4:41 PM logoBecton, Dickinson (BDX) Introduces New Vascular Dressing - Yahoo Finance (NYSE:BDX) - September 21 at 5:13 AM
News IconHigh Market Cap Stock of the Day – Becton, Dickinson and Company (NYSE:BDX) (NYSE:BDX) - September 19 at 4:43 PM logoBecton, Dickinson & Co. – Value Analysis (NYSE:BDX) : September 19, 2016 (NYSE:BDX) - September 19 at 4:43 PM
News IconBecton Dickinson and Co. (BDX) PT Raised to $192.00 at Jefferies ... - NewsDen (NYSE:BDX) - September 19 at 8:33 AM
News Icon13F Filing Note: Rhumbline Advisers Holding in Becton Dickinson And Co Common (BDX) Has Cut by $4.72 Million - Chester News (NYSE:BDX) - September 16 at 3:47 PM
News IconIs Becton, Dickinson and Company (NYSE:BDX), a large market cap stock a smart buy? (NYSE:BDX) - September 16 at 3:47 PM logoBecton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : September 16, 2016 (NYSE:BDX) - September 16 at 3:47 PM logoETF’s with exposure to Becton, Dickinson & Co. : September 16, 2016 (NYSE:BDX) - September 16 at 3:47 PM logoBecton Dickinson and : BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial (NYSE:BDX) - September 16 at 8:19 AM logoBD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial (NYSE:BDX) - September 16 at 8:19 AM logoBecton, Dickinson: Big Earnings Increases Should Bring Big Capital Allocation Increases (NYSE:BDX) - September 15 at 9:26 PM logoWhat Are Analysts’ Recommendations for Stryker? (NYSE:BDX) - September 15 at 4:17 PM
News IconCan Shares Of Becton, Dickinson and Company (NYSE:BDX) Hit $200 (NYSE:BDX) - September 15 at 12:43 PM logoBecton, Dickinson (BDX) Gets USFDA Clearance for BD MAX (NYSE:BDX) - September 15 at 12:43 PM
News IconA look at a High Market Cap Stock: Becton, Dickinson and Company, BDX - The Daily Leicester (NYSE:BDX) - September 14 at 9:01 PM logoBD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions (NYSE:BDX) - September 14 at 3:50 PM logoCurrent report no 62 / 2016 (NYSE:BDX) - September 13 at 8:39 AM
News IconWhat are Research Firms Saying About Becton, Dickinson and Company (NYSE:BDX)? - Frisco Fastball (NYSE:BDX) - September 12 at 3:43 PM logoBD Announces New Software Release For Pyxis Enterprise Solution (NYSE:BDX) - September 12 at 8:35 AM
News IconStock Valuation Recap for Becton, Dickinson and Company (NYSE:BDX) - Post News (NYSE:BDX) - September 10 at 8:32 AM logoBecton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Study Released (NYSE:BDX) - September 9 at 3:44 PM logoBecton, Dickinson and Company (NYSE:BDX) CFF Stands At $6190 Millions (NYSE:BDX) - September 9 at 3:44 PM
News IconBecton, Dickinson and Company (NYSE:BDX) From The Analysts Point of View (NYSE:BDX) - September 9 at 3:44 PM logoHealthcare Stocks Technical Reports -- Skyline Medical; Baxter; Becton, Dickinson; and Hill-Rom - PR Newswire (press release) (NYSE:BDX) - September 9 at 8:36 AM
News IconBecton, Dickinson and Company (NYSE:BDX) From The Analysts Point of View - National Daily Press (NYSE:BDX) - September 9 at 8:36 AM
News IconStock Trading Above Moving Averages: Becton, Dickinson and Company (NYSE:BDX) - Post News (NYSE:BDX) - September 7 at 3:47 PM logoBecton, Dickinson and Company (BDX) Ex-Dividend Date Scheduled for September 07, 2016 - Nasdaq (NYSE:BDX) - September 7 at 10:52 AM logoBD Submits Pre-Market Approval Application to FDA for BD Onclarity™ HPV Test (NYSE:BDX) - September 6 at 8:36 AM logo7:00 am Becton Dickinson has submitted a pre-market approval (:PMA) application to the FDA for the BD Onclarity HPV Assay, its human papillomavirus (:HPV) test (NYSE:BDX) - September 6 at 8:36 AM logoBD to Present at the Morgan Stanley Global Healthcare Conference 2016 (NYSE:BDX) - September 6 at 8:36 AM logoMedtronic’s HeartWare Acquisition: The Must-Know Details (NYSE:BDX) - August 31 at 8:34 AM logoAnalyzing Intuitive Surgical’s Latest Valuation (NYSE:BDX) - August 31 at 8:34 AM
News IconThe Statistics Don't Lie: Becton, Dickinson and Company (NYSE:BDX) Earnings Preview - The Voice Registrar (NYSE:BDX) - August 30 at 3:45 PM logoWhy Intuitive Surgical’s Revenues Are Expected to Be Weaker (NYSE:BDX) - August 30 at 3:45 PM logoMedtronic Registers In-Line Earnings, Missed Revenue Estimates (NYSE:BDX) - August 29 at 4:24 PM logoBecton Dickinson and : Federal Contracts Awarded by Federal Agencies in Louisiana (Aug. 27) (NYSE:BDX) - August 27 at 3:44 PM logoBecton Dickinson and : $264,705 Federal Contract Awarded to Becton, Dickinson & Co. (NYSE:BDX) - August 27 at 8:35 AM logoCurrent report no 60 / 2016 (NYSE:BDX) - August 26 at 11:53 AM logoBecton, Dickinson and Company (NYSE:BDX) Paying Out $-485 Million In Dividends (NYSE:BDX) - August 25 at 9:13 PM


Becton Dickinson and (NYSE:BDX) Chart for Wednesday, September, 28, 2016

Last Updated on 9/28/2016 by Staff